Ron Bentsur
Affiliations
- Chairman & Ceo at Nuvectis Pharma Inc. (NVCT), 2024-11-18
- Director at Beyond Air Inc. (XAIR), 2024-03-22
- Director at Stemline Therapeutics Inc (STML), 2020-06-10
- Chief Executive Officer at Urogen Pharma Ltd. (URGN), 2019-01-10
- Chief Executive Officer at Keryx Biopharmaceuticals Inc (KERX), 2015-04-09
Insider Trading: Purchases See All
Company | Symbol | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|---|
NVCT | $4.92 | 20,000 | Large Shareholder, Officer, Director | 3,266,424 | 2024-11-15 | Filing | |
NVCT | $6.74 | 1,940 | Large Shareholder, Officer, Director | 3,246,424 | 2024-05-14 | Filing | |
NVCT | $6.40 | 2,000 | Large Shareholder, Officer, Director | 3,244,484 | 2024-05-10 | Filing | |
NVCT | $10.29 | 5,000 | Large Shareholder, Officer, Director | 3,242,484 | 2024-03-18 | Filing | |
NVCT | $11.08 | 640 | Large Shareholder, Officer, Director | 3,237,484 | 2023-10-10 | Filing |
Insider Trading: Sales See All
Company | Symbol | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|---|
XAIR | $6.53 | 40,000 | Director | 142,436 | 2022-06-30 | Filing | |
XAIR | $13.99 | 6,464 | Director | 182,436 | 2021-11-24 | Filing | |
XAIR | $13.44 | 31,000 | Director | 188,900 | 2021-11-24 | Filing | |
XAIR | $6.36 | 23,419 | Director | 182,436 | 2021-02-12 | Filing | |
XAIR | $6.28 | 1,500 | Director | 182,436 | 2021-02-11 | Filing |